Patents by Inventor Malin CARLSSON

Malin CARLSSON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics
    Patent number: 11795216
    Abstract: The invention relates to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of inflammatory disorders such as rheumatoid arthritis according to specific dosing regimen. The invention relates also to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of pain, e.g. pain experienced in inflammatory disorders such as rheumatoid arthritis, according to specific dosage regimen.
    Type: Grant
    Filed: August 17, 2020
    Date of Patent: October 24, 2023
    Assignee: Takeda Pharmaceutical Company Limited
    Inventors: Thomas Wagner, Malin Carlsson, Margit Staum Kaltoft
  • ANTIBODIES NEUTRALIZING GM-CSF FOR USE IN THE TREATMENT OF RHEUMATOID ARTHRITIS OR AS ANALGESICS
    Publication number: 20210171620
    Abstract: The invention relates to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of inflammatory disorders such as rheumatoid arthritis according to specific dosing regimen. The invention relates also to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of pain, e.g. pain experienced in inflammatory disorders such as rheumatoid arthritis, according to specific dosage regimen.
    Type: Application
    Filed: August 17, 2020
    Publication date: June 10, 2021
    Applicant: Takeda GmbH
    Inventors: Thomas WAGNER, Malin CARLSSON, Margit STAUM KALTOFT
  • Antibodies neutralizing GM-CSF for use in the treatment of rheumatoid arthritis or as analgesics
    Patent number: 10745475
    Abstract: The invention relates to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of inflammatory disorders such as rheumatoid arthritis according to specific dosing regimen. The invention relates also to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of pain, e.g. pain experienced in inflammatory disorders such as rheumatoid arthritis, according to specific dosage regimen.
    Type: Grant
    Filed: September 1, 2014
    Date of Patent: August 18, 2020
    Assignee: TAKEDA GMBH
    Inventors: Thomas Wagner, Malin Carlsson, Margit Staum Kaltoft
  • ANTIBODIES NEUTRALIZING GM-CSF FOR USE IN THE TREATMENT OF RHEUMATOID ARTHRITIS OR AS ANALGESICS
    Publication number: 20160355584
    Abstract: The invention relates to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of inflammatory disorders such as rheumatoid arthritis according to specific dosing regimen. The invention relates also to neutralizing antibodies of GM-CSF and compositions comprising the same for use in the treatment of pain, e.g. pain experienced in inflammatory disorders such as rheumatoid arthritis, according to specific dosage regimen.
    Type: Application
    Filed: September 1, 2014
    Publication date: December 8, 2016
    Inventors: Thomas WAGNER, Malin CARLSSON, Margit STAUM KALTOFT